hVIVO PLC (LSE:HVO) - Share price - Overview

Stock Report

hVIVO PLC HVO

Last Price
GBX128.00

Day Change
0.00|0.00%

As of 24/04/2017
10:34:09 BST | GBX
Minimum 15 Minutes Delay.

Last Close128.00p
Day Range131.50 - 131.50
Mkt Cap100.00Mil
52-Wk Range119.00 - 239.75
Yield %0.00
ISINGB00B6ZM0X53
Volume4,011
P/E-5.59
P/S11.44
P/CF-9.34

Share Price

Total Returns 24/04/2017

 Chg (%)  
More ...
hVIVO PLC0.00 
FTSE 100 TR GBP-0.69
 
Financials
201420152016
More ...
Income Statement
Turnover18.477.72-
Operating Profit-23.05-22.00-
Net Profit-18.44-17.91-
Reported EPS-31.30-26.00-
Balance Sheet
Current Assets61.2763.06-
Non Current Assets8.2121.69-
Total Assets69.4884.74-
Current Liabilities4.6217.50-
Total Liabilities8.3021.12-
Total Equity61.1863.62-
Cash Flow
Operating Cash Flow-19.15-13.60-
Net Change in Cash9.52-8.63-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-17.30-16.80--7.62---
2018-17.10-17.50--7.31---

Regulatory News

DateSourceHeadline
More ...
20/04/2017|07:00RNShVIVO plc - Audited 2016 Preliminary Results
13/04/2017|07:00RNShVIVO plc - Trading Update
05/04/2017|07:00RNShVIVO plc - Directors' Dealings
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
09/01/2017PurchaseMr Jaime Ellertson161.0010,11416,284.00
09/01/2017PurchaseMr. Jim Winschel161.002,4843,999.00
17/10/2016PurchaseMr Jaime Ellertson180.108,54615,391.00
17/10/2016PurchaseMr. Jim Winschel180.102,2214,000.00

Company Profile

hVIVO PLC is a life science company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases.

Sector

Biotechnology

Market Position

916 of 1849 Companies

Index

Outlook

(20/04/2017) no outlook statement

Next Event 28/04/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-7.5213.9516.14
Div Yld (E)0.003.834.14
PEG (E)0.000.331.08
ROCE0.00179.07-76.14
Op Mrgn0.00-8.80-16.63
EPS Grwth0.0070.7731.27
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Jaime Ellertson
Chief Executive OfficerKym Denny
Chief Financial & Business Officer & CSGraham Yeatman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.